Comment
doi: 10.1038/s41590-022-01159-5.
Modulating the tumor-associated macrophage landscape
Affiliations
- PMID: 35314847
- DOI: 10.1038/s41590-022-01159-5
Item in Clipboard
Comment
Modulating the tumor-associated macrophage landscape
Nat Immunol.
2022 Apr.
No abstract available
Comment on
-
Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunity.Nat Immunol. 2022 Apr;23(4):568-580. doi: 10.1038/s41590-022-01153-x. Epub 2022 Mar 21. Nat Immunol. 2022. PMID: 35314846
Similar articles
-
Comprehensive Integrative Analysis Reveals the Association of KLF4 with Macrophage Infiltration and Polarization in Lung Cancer Microenvironment.Cells. 2021 Aug 14;10(8):2091. doi: 10.3390/cells10082091. Cells. 2021. PMID: 34440860 Free PMC article.
-
The role of macrophages during breast cancer development and response to chemotherapy.Clin Transl Oncol. 2020 Nov;22(11):1938-1951. doi: 10.1007/s12094-020-02348-0. Epub 2020 Apr 11. Clin Transl Oncol. 2020. PMID: 32279178 Review.
-
FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.Theranostics. 2020 Sep 16;10(25):11535-11548. doi: 10.7150/thno.45261. eCollection 2020. Theranostics. 2020. PMID: 33052231 Free PMC article.
-
Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.Cancer Res. 2021 Feb 15;81(4):956-967. doi: 10.1158/0008-5472.CAN-20-1885. Epub 2020 Dec 8. Cancer Res. 2021. PMID: 33293426
-
Tumor-associated macrophage-targeted therapeutics in ovarian cancer.Int J Cancer. 2021 Jul 1;149(1):21-30. doi: 10.1002/ijc.33408. Epub 2020 Dec 4. Int J Cancer. 2021. PMID: 33231290 Review.
Cited by
-
Therapeutic targeting of tumour-associated macrophage receptors.Immunother Adv. 2025 Mar 11;5(1):ltaf009. doi: 10.1093/immadv/ltaf009. eCollection 2025. Immunother Adv. 2025. PMID: 40385641 Free PMC article. Review.
-
A novel classifier combining G protein-coupled receptors and the tumor microenvironment is associated with survival status in glioblastoma.Front Pharmacol. 2023 Jul 25;14:1093263. doi: 10.3389/fphar.2023.1093263. eCollection 2023. Front Pharmacol. 2023. PMID: 37560473 Free PMC article.
-
A timeline of tumour-associated macrophage biology.Nat Rev Cancer. 2023 Apr;23(4):238-257. doi: 10.1038/s41568-022-00547-1. Epub 2023 Feb 15. Nat Rev Cancer. 2023. PMID: 36792751 Review.
-
Improving the efficacy of immunotherapy for colorectal cancer: Targeting tumor microenvironment-associated immunosuppressive cells.Heliyon. 2024 Aug 16;10(16):e36446. doi: 10.1016/j.heliyon.2024.e36446. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39262952 Free PMC article. Review.
-
Bioactive metallic nanoparticles for synergistic cancer immunotherapy.Acta Pharm Sin B. 2025 Apr;15(4):1869-1911. doi: 10.1016/j.apsb.2025.02.022. Epub 2025 Feb 21. Acta Pharm Sin B. 2025. PMID: 40486836 Free PMC article. Review.
References
-
- Ozga, A. J., Chow, M. T. & Luster, A. D. Immunity 54, 859–874 (2021). - DOI
-
- Vanheule, V., Metzemaekers, M., Janssens, R., Struyf, S. & Proost, P. Cytokine 109, 29–51 (2018). - DOI
-
- Barreira da Silva, R. et al. Nat. Immunol. https://doi.org/10.1038/s41590-022-01153-x (2022). - DOI - PubMed
-
- Nagarsheth, N., Wicha, M. S. & Zou, W. Nat. Rev. Immunol. 17, 559–572 (2017). - DOI
-
- Ortiz Zacarias, N. V., Bemelmans, M. P., Handel, T. M., de Visser, K. E. & Heitman, L. H. Trends Pharmacol. Sci. 42, 912–928 (2021). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
